Coping as a multisystem construct associated with pathways mediating HIV-relevant immune function and disease progression

Psychosomatic Medicine

Volumn 70, Issue 5, 2008, Pages 555-561

  Temoshok, Lydia R ^a   Wald, Rebecca L ^a   Synowski, Stephen ^a   Garzino Demo, Alfredo ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokines; Coping; HIV AIDS; Immune activation; Psychoneuroimmunology; Type C

Indexed keywords

CHEMOKINE RECEPTOR CCR5 ANTAGONIST; CYTOKINE;

AUTONOMIC NERVOUS SYSTEM; BEHAVIOR; BIOLOGY; COGNITION; COPING BEHAVIOR; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE COURSE; EMOTION; ENVIRONMENTAL FACTOR; HEALTH BEHAVIOR; HOMEOSTASIS; HOST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MEDICAL RESEARCH; MENTAL HEALTH; PHYSIOLOGY; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; REVIEW; STRESS; VIRUS REPLICATION; ADAPTIVE BEHAVIOR; CD4 LYMPHOCYTE COUNT; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOLOGY; LIFE EVENT; PATHOPHYSIOLOGY; PATIENT ATTITUDE; PROGNOSIS; PSYCHOLOGICAL ASPECT;

ADAPTATION, PSYCHOLOGICAL; AUTONOMIC NERVOUS SYSTEM; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; HIV INFECTIONS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIFE CHANGE EVENTS; PITUITARY-ADRENAL SYSTEM; PROGNOSIS; PSYCHONEUROIMMUNOLOGY; SICK ROLE;

EID: 50949102388     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e318177354f     Document Type: Review

References (77)

1. Solomon GF, Temoshok L. A psychoneuroimmunologic perspective on AIDS research: questions, preliminary findings, and suggestions. J Appl Soc Psychol 1987;17:286-308.
2. Hulgan T, Shepherd BE, Raffanti SP, Fusco JS, Beckerman R, Barkanic G, Sterling TR. Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy. J Infect Dis 2007;195: 425-431
3. Cruess DG, Leserman J, Petitto JM, Golden RN, Szuba MP, Morrison MF, Evans DL. Psychosocial-immune relationships in HIV disease. Se-min Clin Neuropsychiatry 2001;6:241-251
4. Kopinsky KL, Stoff DM, Rausch DM. Workshop report: the effects of psychological variables on the progression of HIV-1 disease. Brain Behavior Immunity 2004;18:246-261
5. Sloan EK, Collado-Hidalgo A, Cole S. Psychobiology of HIV infection. In: Ader R, editor. Psychoneuroimmunology. Fourth Edition. Vol.2. Burlington, MA: Elsevier Academic Press; 2007.
6. Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med 2008;70:539-545
7. Ironson G, Hayward H. Do positive psychosocial factors predict disease progression in HIV? A review of the evidence. Psychosom Med 2008; 70:546-554
8. Lazarus RS. The stress and coping paradigm. In: Bond LA, Rosen JC, editors. Competence and Coping During Adulthood. Hanover, NH: University of New England Press; 1980.
9. McEwen BS, Stellar E. Stress and the individual: mechanisms leading to disease. Arch Intern Med 1993;153:2093-2101
10. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998;338:171-179
11. Sterling P, Eyer J. Allostasis: a new paradigm to explain arousal pathology. In: Fisher S, Reason J, editors. Handbook of Life Stress, Cognition and Health. New York: John Wiley; 1998.
12. Temoshok L. Emotion, adaptation, and disease: a multidimensional model. In: Temoshok L, Van Dyke C, Zegans LS, editors. Emotions in Health and Illness: Theoretical and Research Foundations. New York: Grune & Stratton; 1983.
13. Temoshok L. Personality, coping style, emotion, and cancer: toward an integrative model. Cancer Surv 1987;6:837-857
14. Temoshok L. On attempting to articulate the biopsychosocial model: psychological-psychophysiological homeostasis. In: Friedman H, editor. Personality and Disease. New York: John Wiley and Sons; 1990.
15. Temoshok L. Complex coping patterns and their role in adaptation and neuroimmunomodulation: theory, methodology, and research. Ann N Y Acad Sci 2000;917:446-455
16. Temoshok LR. Connecting the dots linking mind, behavior, and disease: the biological concomitants of coping patterns. Integrative Cancer Ther 2002;1:387-391
17. Kemeny ME, Dean L. Effects of AIDS-related bereavement on HIV progression among New York City gay men. AIDS Educ Prev 1995;7(5 Suppl):36-47.
18. Reed G, Kemeny M, Taylor S, Visscher B. Negative HIV-specific expectancies and AIDS-related bereavement as predictors of symptom onset in asymptomatic HIV-positive gay men. Health Psychol 1999;18: 354-363
19. Segerstrom SC, Taylor SE, Kemeny ME, Reed GM, Visscher BR. Causal attributions predict rate of immune decline in HIV-seropositive gay men. Health Psychol 1996;15:485-493
20. Milam J, Richardson J, Marks G, Kemper C, Mccutchan A. The roles of dispositional optimism and pessimism in HIV disease progression. Psychol Health 2004;19:167-181
21. Byrnes DM, Antoni MH, Goodkin K, Efantis-Potter J, Asthana D, Simon T, Munajj J, Ironson G, Fletcher MA. Stressful events, pessimism, natural killer cell cytotoxicity, and cytotoxic/suppressor T cells in HIV+ black women at risk for cervical cancer. Psychosom Med 1998;60:714-722
22. Blomkvist V, Theorell T, Jonsson H, Schulman S, Berntorp E, Stiegendal L. Psychosocial self-prognosis in relation to mortality and morbidity in hemophiliacs with HIV infection. Psychother Psychosom 1994;39: 957-965
23. Ironson G, Balbin E, Stuetzle R, Fletcher MA, O'Cleirigh C, Laurenceau JP, Schneiderman N, Solomon G. Dispositional optimism and the mechanisms by which it predicts slower disease progression in HIV: proactive behavior, avoidant coping, and depression. Int J Behav Med 2005;2: 86-97.
24. Reed G, Kemeny M, Taylor S, Wang H, Visscher B. Realistic acceptance as a predictor of decreased survival time in gay men with AIDS. Health Psychol 1994;13:299-330
25. Tomakowsky J, Lumley M, Markowitz N, Frank C. Optimistic explanatory style and dispositional optimism in HIV-infected men. J Psychosom Res 2001;51:577-587
26. Gore-Felton C, Koopman C. Behavioral mediation of the relationship between psychosocial factors and HIV disease progression. Psychosom Med 2008;70:569-574
27. Bower JE, Kemeny ME, Taylor SE, Fahey JL. Cognitive processing, discovery of meaning, CD4 decline, and AIDS-related mortality among bereaved HIV-seropositive men. J Consult Clin Psychol 1998;66: 979-986
28. Vassend P, Eskild A, Halvorsen R. Negative affectivity, coping, immune status, and disease progression in HIV-infected individuals. Psychol Health 1997;12:375-388
29. Vassend O, Eskild A. Psychological distress, coping, and disease progression in HIV-positive homosexual men. J Health Psychol 1998;3: 243-257
30. Temoshok L, Heller BW. Stress and "type C" versus epidemiological risk factors in melanoma. Proceedings of the 89th Annual Convention of the American Psychological Association, Los Angeles, August 1981. Washington, DC: American Psychological Association; 1981.
31. Temoshok L, Heller BW, Sagebiel RW, Blois MS, Sweet DM, DiClemente RJ, Gold ML. The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma. J Psychosom Res 1985;29:139-153
32. Temoshok L. Biopsychosocial studies on cutaneous malignant melanoma: Psychosocial factors associated with prognostic indicators, progression, psychophysiology, and tumor-host response. Soc Sci Med 1985;20:833-840
33. Temoshok L, Dreher H. The Type C Connection: The Behavioral Links to Cancer and Your Health. New York: Random House; 1992.
34. Temoshok LR. Type C coping and cancer progression. In: Fernandez-Ballesteros R, editor. The Encyclopedia of Psychological Assessment. Vol 2. New York: Sage; 2003.
35. Temoshok LR. Type C coping/behavior pattern. In: Christensen AJ, Martin R, Smyth JM, editors. Health Psychology. New York: Plenum; 2004.
36. Kneier AW, Temoshok L. Repressive coping reactions in patients with malignant melanoma as compared to cardiovascular disease patterns. J Psychosom Res 1984;28:145-155
37. Solomon GF, Kemeny M, Temoshok L. Psychoneuroimmunologic aspects of human immunodeficiency virus infection. In: Ader R, Felten DL, Cohen N, editors. Psychoneuroimmunology II. Orlando, FL: Academic Press; 1991.
38. Temoshok L. The complexity of cause: Linking emotional dynamics to health outcomes in cancer and HIV/AIDS. In: Vingerhoets AJJM, Van Bussel F, Boelhouwer AJW, editors. The (non)Expression of Emotions in Health and Disease. Tilburg, Netherlands: Tilburg University Press; 1997.
39. Solano L, Costa M, Salvati S, Coda R, Aiuti F, Mezzaroma I, Bertini M. Psychosocial factors and clinical evolution in HIV-infection: a longitudinal study. J Psychosom Res 1993;37:39-51.
40. Solano L, Costa M, Temoshok L, Salvati S, Coda R, Aiuti F, Di Sora F, D'Offizi G, Figa-Talamanca L, Mezzaroma I, Montella F, Bertini M. An emotionally inexpressive (type C) coping style influences HIV disease progression at six and twelve month follow-ups. Psychol Health 2002;7: 641-655
41. Vergis EN, Mellors JW. Natural history of HIV-1 infection. Infect Dis Clin North Am 2000;14:809-816
42. Temoshok LR, Waldstein SR, Wald RL, Garzino-Demo A, Synowski SJ, Wiley JA. Type C coping, alexithymia, and heart rate reactivity are associated independently and differentially with specific immune mechanisms linked to HIV progression. Brain Behav Immunity 2008 Mar 16 [Epub ahead of print]; doi: 10.1016/j.bbi. 2008;02.003.
43. Poli G, Bressler P, Kinter A, Duh E, Timmer WC, Rabson A, Justement JS, Stanley S, Fauci AS. Interleukin 6 induces human immunodeficiency virus expression in infected monocyte cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J Exp Med 1990;172:151-158
44. Lawn SD, Butera ST, Folks TM. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev 2001;14:753-777
45. O'Cleirigh C, Ironson G, Antoni M, Fletcher MA, McGuffey L, Balbin E, Schneiderman N, Solomon G. Emotional expression and depth processing of trauma and their relation to long-term survival in patients with HIV/AIDS. J Psychosom Res 2003;54:225-235
46. Ashton E, Vosvick M, Chesney M, Gore-Felton C, Koopman C, O'Shea K, Maldonado J, Bachmann MH, Israelski D, Flamm J, Spiegel D. Social support and maladaptive coping as predictors of the change in physical health symptoms among persons living with HIV/AIDS. AIDS Patient Care STDS 2005;19:587-598
47. Taylor GJ. Alexithymia: 25 years of theory and research. In: Nykĺic?ek I, Temoshok L, Vingerhoets A, editors. Emotional Expression and Health: Advances in Theory, Assessment and Clinical Applications. New York: Brunner-Routledge; 2004.
48. Garssen B, Remie M. Different concepts or different words? Concepts related to non-expression of negative emotions. In: Nykĺic?ek I, Temoshok L, Vingerhoets A, editors. Emotional Expression and Health: Advances in Theory, Assessment and Clinical Applications. New York: Brunner-Routledge; 2004.
49. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1a and MIP-1/3 as the major HIV-suppressive factor produced by CD8+ cells. Science 1995;270:1811-1815.
50. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Ann Rev Immunol 1999;17:657-700.
51. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-673
52. Gorry PR, Churchill M, Crowe SM, Cunninghan AL, Gabuzda D. Pathogenesis of macrophage tropic HIV-1. Curr HIV Res 2005;3:53-60.
53. Garzino-Demo A, Moss RB, Margolick JB, Cleghorn F, Sill A, Blattner WA, Cocchi F, Carlo DJ, DeVico AL, Gallo RC. Spontaneous and antigen-induced production of HIV-inhibitory /3-chemokines are associated with AIDS-free status. Proc Natl Acad Sci 1999;96:11986-11991
54. Cocchi F, DeVico A, Yarchoan R, Redfield R, Cleghorn F, Blattner W, Garzino-Demo A, Colombini-Hatch S, Margolis D, Gallo R. Higher macrophage inflammatory protein (MIP)-1a and MIP-1/3 levels from CD8+ T cells are associated with asymptomatic HIV-1 infection. Proc Natl Acad Sci USA 2000;97:13812-13817
55. Garzino-Demo A. Chemokines and defensins as HIV suppressive factors: an evolving story. Curr Pharm Des 2007;13:163-172
56. Ullum H, Cozzi A, Victor J, Aladdin A, Phillips AN, Gerstoft J, Skinhej P, Pedersen BK. Production of beta-chemokines in human immunodeficiency virus (HIV-1) infection: evidence that high levels of macrophage inflammatory protein-1 beta are associated with a decreased risk of HIV disease progression. J Infect Dis 1998;33:331-336
57. Goodkin K, Fuchs I, Feaster D, Leeka J, Rishel D. Life stressors and coping style are associated with immune measures in HIV-1 infection-a preliminary report. Int J Psychiatry Med 1992;22:155-172
58. Ironson G, O'Cleirigh C, Fletcher MA, Laurenceau JP, Balbin E, Klimas N, Schneiderman N, Solomon G. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med 2005;67:1013-1021
59. Antoni MH, Goldstein D, Ironson G, LaPerriere A, Fletcher MA, Schneiderman N. Coping responses to HIV-1 serostatus notification predict concurrent and prospective immunologic status. Clin Psychol Psychother 1995;2: 234-248
60. Leserman J, Pettito JM, Golden RN, Gaynes BN, Gu H, Perkins DO, Silva SG, Folds JD, Evans DL. Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS. Am J Psychiatry 2000;157:1221-1228
61. Ironson G, Friedman A, Klimas N, Antoni M, Fletcher MA, Laperriere A, Simoneau J, Schneiderman N. Distress, denial, and low adherence to behavioral interventions predict faster disease progression in gay men infected with human immunodeficiency virus. Int J Behav Med 1994;1: 90-105.
62. Cole S, Kemeny M, Taylor S, Visscher B, Fahey J. Accelerated course of human immunodeficiency virus infection in gay men who conceal their homosexual identity. Psychosom Med 1996;58:219-231 (Pubitemid 26181490)
63. Wald RL, Dowling GC, Temoshok LR. Coping styles predict immune system parameters and clinical outcomes in patients with HIV. Retrovirol 2006;3(Suppl 1):P65.
64. Strachan E, Bennett W, Russo J, Roy-Byrne P. Disclosure of HIV status and sexual orientation independently predicts increased absolute CD4 cell counts over time for psychiatric patients. Psychosom Med 2007;69: 74-80.
65. Mulder C, Antoni M, Duivenvoorden H, Kauffmann R, Goodkin K. Active confrontational coping predicts decreased clinical progression over a one-year period in HIV-infected homosexual men. J Psychosom Res 1995;39:957-965
66. Ickovics J, Milan S, Boland R, Schoenbaum E, Schuman P, Vlahov D. Psychological resources protect health: 5-year survival and immune function among HIV-infected women from four US cities. AIDS 2006;11: 1851-1860
67. Glaser R, Rabkin B, Chesney M, Cohen S, Natelson B. Stress-induced immunomodulation: implications for infectious diseases? J Am Med Assoc 1999;281:2268-2270
68. Hurwitz B, Brownley K, Motivala S, Milanovich JR, Kibler JL, Fillion L, LeBlanc WG, Kumar M, Klimas NG, Fletcher MA, Schneiderman N. Sympathoimmune anomalies underlying the response to stressful challenge in human immunodeficiency virus spectrum disease. Psychosom Med 2005;67:798-806.
69. Cole S. Psychosocial influences on HIV-1 disease progression: neural, endocrine and virologic mechanisms. Psychosom Med 2008:70: 562-568
70. Cole S, Korin Y, Fahey J, Zack J. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol 1998;161:610-616
71. Cole S, Naliboff B, Kemeny M, Griswold M, Fahey J, Zack J. Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Nat Acad Sci USA 2001;98: 12695-12700
72. Temoshok L, Zich J, Solomon GF, Stites DP. An intensive psychoimmunologic study of long-surviving persons with AIDS. Proceedings of the III International Conference on AIDS, Washington DC, 1987.
73. O'Leary A, Temoshok L, Jenkins SR, Sweet DM. Autonomic reactivity and immune function in men with AIDS. Psychophysiology 1989;26:S47.
74. Robles TF, Glaser R, Kiecolt-Glaser JK. Out of balance: a new look at chronic stress, depression, and immunity. Curr Dir Psychol Sci 2005;14: 111-115
75. Kinter A, Arthos J, Cicala C, Fauci AS. Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis. Immunolg Rev 2000;177:88-98.
76. Temoshok L. Rethinking research on psychosocial interventions in bio-psychsocial oncology. Psycho-Oncology 2004;13:460-467
77. Temoshok LR, Wald RL. Change is complex: rethinking research on psychosocial interventions and cancer. Int Cancer Ther 2002;1:135-145